Areteia Therapeutics Announces Positive Topline Results from the First Phase III Study of Oral Dexpramipexole in Eosinophilic Asthma
-
16/07/2025, 13:13
-
ansa.it
0
Scopri altro
- 16/09/2025, 13:13
-
ansa.it
-
0
- 16/09/2025, 13:13
-
ansa.it
-
0
- 16/09/2025, 12:57
-
ansa.it
-
0
- 16/09/2025, 12:55
-
ansa.it
-
0
- 16/09/2025, 12:51
-
ansa.it
-
0
- 16/09/2025, 12:51
-
ansa.it
-
0
- 16/09/2025, 12:38
-
lastampa.it
-
0
Nessun commento